4/A//SEC Filing
ELITE PHARMACEUTICALS INC /NV/ 4/A
Accession 0001053369-15-000031
$ELTPCIK 0001053369operating
Filed
May 12, 8:00 PM ET
Accepted
May 13, 7:52 PM ET
Size
7.6 KB
Accession
0001053369-15-000031
Insider Transaction Report
Form 4/AAmended
NARINE JEENARINE
Director10% Owner
Transactions
- Sale
Common Stock
2014-04-01$0.41/sh−157,012$64,626→ 5,830,544 total - Sale
Common Stock
2014-04-02$0.41/sh+147,667$60,543→ 5,682,877 total
Holdings
- 14,887,229(indirect: By LLC)
Common Stock
Footnotes (4)
- [F1]The original filing inadvertently did not include this transaction.
- [F2]The original filing inadvertently under reported the transaction by three shares.
- [F3]Jeenarine Narine is an equity owner and executive officer of each of Epic Investments, LLC (EI)and Epic Pharma, LLC (EP), which is a 10% owner of the issuer, and also serves as a director of the issuer.
- [F4]Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
Documents
Issuer
ELITE PHARMACEUTICALS INC /NV/
CIK 0001053369
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0001053369
Filing Metadata
- Form type
- 4/A
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 7:52 PM ET
- Size
- 7.6 KB